Trial · NCT03118570
Results by group335
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 335
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Radial Trabecular Volumetric Bone Mineral Density (Tr vBMD) at Month 12 | Setrusumab 20 mg/kg (Blinded) | 1.004 | 95% Confidence Interval 0.987 to 1.021 | ratio | |
| Change From Baseline in Radial Trabecular Volumetric Bone Mineral Density (Tr vBMD) at Month 12 | Setrusumab 8 mg/kg (Blinded) | 0.993 | 95% Confidence Interval 0.975 to 1.012 | ratio | |
| Change From Baseline in Radial Trabecular Volumetric Bone Mineral Density (Tr vBMD) at Month 12 | Setrusumab 2 mg/kg (Blinded) | 0.992 | 95% Confidence Interval 0.974 to 1.011 | ratio | |
| Change From Baseline in Radial Bone Strength (Failure Load) at Month 12 | Setrusumab 20 mg/kg (Blinded) | 61.25 | Standard Error 21.669 | newton (N) | |
| Change From Baseline in Radial Bone Strength (Failure Load) at Month 12 | Setrusumab 8 mg/kg (Blinded) | 32.25 | Standard Error 24.342 | newton (N) | |
| Change From Baseline in Radial Bone Strength (Failure Load) at Month 12 | Setrusumab 2 mg/kg (Blinded) | 8.86 | Standard Error 23.200 | newton (N) | |
| Change From Baseline in Radial Bone Strength (Stiffness) at Month 12 | Setrusumab 20 mg/kg (Blinded) | 1638.70 | Standard Error 625.808 | N/mm | |
| Change From Baseline in Radial Bone Strength (Stiffness) at Month 12 | Setrusumab 8 mg/kg (Blinded) | 1422.00 | Standard Error 703.275 | N/mm | |
| Change From Baseline in Radial Bone Strength (Stiffness) at Month 12 | Setrusumab 2 mg/kg (Blinded) | 209.89 | Standard Error 671.777 | N/mm | |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 20 mg/kg (Blinded) | Radial: Month 6 | 1.007 | 95% Confidence Interval 0.993 to 1.021 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 8 mg/kg (Blinded) | Radial: Month 6 | 1.000 | 95% Confidence Interval 0.986 to 1.015 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 2 mg/kg (Blinded) | Radial: Month 6 | 0.998 | 95% Confidence Interval 0.984 to 1.013 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 20 mg/kg (Blinded) | Radial: Month 12 | 1.004 | 95% Confidence Interval 0.987 to 1.021 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 8 mg/kg (Blinded) | Radial: Month 12 | 0.993 | 95% Confidence Interval 0.975 to 1.012 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 2 mg/kg (Blinded) | Radial: Month 12 | 0.992 | 95% Confidence Interval 0.974 to 1.011 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 20 mg/kg (Blinded) | Radial: Month 18 | 1.002 | 95% Confidence Interval 0.984 to 1.020 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 8 mg/kg (Blinded) | Radial: Month 18 | 0.992 | 95% Confidence Interval 0.973 to 1.013 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 2 mg/kg (Blinded) | Radial: Month 18 | 0.979 | 95% Confidence Interval 0.962 to 0.997 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 20 mg/kg (Blinded) | Radial: Month 24 | 0.997 | 95% Confidence Interval 0.972 to 1.023 | ratio |
| Change From Baseline in Radial and Tibial Tr VBMD Over Time: Full Analysis Set | Setrusumab 8 mg/kg (Blinded) | Radial: Month 24 | 0.998 | 95% Confidence Interval 0.970 to 1.027 | ratio |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03118570/results